Redcliffe Labs

Redcliffe Labs

Private
Noida, Uttar PradeshHealthcare & Life Scienceshttps://www.redcliffelabs.com

Last Round

Series C

Sep 17, 2024

Total Funding Raised

$103M

Company Overview

Redcliffe Labs is a diagnostics and precision medicine company that provides reproductive health testing, rare disease assessments, and cancer gene diagnosis, utilizing in-house technology to deliver comprehensive screening services along with counseling and clinical data management.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Precision Medicine, Biotechnology, Last-Mile Delivery, Patient Engagement

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

diagnostic servicesat-home sample collectionlab test at homepreventive health checkupspathology servicesdiagnostics chaingenetic testingomnichannel diagnosticsdigital reportsD2C diagnosticspreventive diagnosticslab networkcorporate health checkupsradiology servicesAI wellness screeningPCOS diagnosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Redcliffe Labs Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Redcliffe Labs Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CSep 17, 2024
Private EquityJul 6, 2022
Series BMay 6, 2022

Key People

Founding team and executive leadership

Aditya Kandoi

Founder CEO

Founding Team

Pradeep Tomar

Deputy CTO

Executive Team

Alka Saxena

CFO

Executive Team

Redcliffe Labs Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 20, 2026

    Partnered with Roche Diagnostics India to launch a new PCOS blood test.

  • Mar 20, 2026

    Elecsys AMH Plus blood test for PCOS is now available.

Redcliffe Labs Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Redcliffe Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Redcliffe Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersNoida, Uttar Pradesh
Employee Range1,908
Year Founded2018
Last FundingSep 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.